AngioDynamics ANGO Business Segments
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| Gross Profit by Business | ||||||
| Med Device | $80.72M-1.3% | $81.8M+2.1% | $80.1M+1.1% | $79.19M+1.8% | $77.81M-0.9% | |
| Med Tech | $89.62M+4.3% | $85.91M+3.8% | $82.74M+5.4% | $78.52M+3.0% | $76.2M+5.1% | |
| Cost of sales (exclusive of intangible amortization) by Business | ||||||
| Med Device | $89.02M+1.8% | $87.46M+0.9% | $86.67M0.0% | $86.65M-4.7% | $90.89M-6.3% | |
| Med Tech | $54.37M+4.3% | $52.13M+1.8% | $51.21M+6.4% | $48.14M+11.3% | $43.27M+4.7% | |
| Net Sales by Product | ||||||
| Med Device | $169.74M+0.3% | $169.26M+1.5% | $166.77M+0.6% | $165.84M+1.7% | $163.12M-5.0% | |
| Med Tech | $143.99M+4.3% | $138.05M+3.1% | $133.95M+5.8% | $126.65M+5.4% | $120.2M+4.8% | |
| Net Sales by Geography | ||||||
| International | $44.91M+1.1% | $44.43M+3.9% | $42.76M+3.0% | $41.52M+6.2% | $39.08M-5.3% | |
| United States | $268.81M+2.3% | $262.87M+1.9% | $257.96M+2.8% | $250.98M+2.8% | $244.24M-0.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does AngioDynamics break its business down?
- AngioDynamics (ANGO) reports gross profit by business across 2 parts — Med Device and Med Tech. Each is extracted from the segment footnotes and tracked over time.
- Where does AngioDynamics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in AngioDynamics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
